Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Zidovudine and Lamivudine Tablets

Approval Number

国药准字H20213700

Company东北制药集团沈阳第一制药有限公司

Registration Date

September 7, 2021

Drug Information

Generic Name

齐多拉米双夫定片

Dosage Form

片剂

Strength

每片含齐多夫定300mg和拉米夫定150mg

Drug Type

化学药品

Registration Date

September 7, 2021

Company Information

Applicant Company

Company Name东北制药集团沈阳第一制药有限公司

Company Address

沈阳经济技术开发区昆明湖街8号

Manufacturing Company

Company Name东北制药集团沈阳第一制药有限公司

Company Address

沈阳经济技术开发区昆明湖街8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy